Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis
Public ClinicalTrials.gov record NCT03573336. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
Study identification
- NCT ID
- NCT03573336
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bayer
- Industry
- Enrollment
- 8 participants
Conditions and interventions
Conditions
Interventions
- Vilaprisan (BAY1002670) Drug
- Matching Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 3, 2018
- Primary completion
- Mar 17, 2019
- Completion
- Nov 25, 2020
- Last update posted
- May 3, 2022
2018 – 2020
United States locations
- U.S. sites
- 6
- U.S. states
- 4
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Office of Dr. James A. Simon, MD | Washington D.C. | District of Columbia | 20036 | — |
| Helix Biomedics, LLC | Boynton Beach | Florida | 33435 | — |
| Solutions Through Advanced Research, Inc. | Jacksonville | Florida | 32256 | — |
| Southern Clinical Research Associates LLC | Metairie | Louisiana | 70001 | — |
| Unified Women's Clinical Research - Morehead City | Morehead City | North Carolina | 28557 | — |
| Unified Women's Clinical Research | Winston-Salem | North Carolina | 27103 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03573336, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2022 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03573336 live on ClinicalTrials.gov.